Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 2000 Jan 18;82(2):441–445. doi: 10.1054/bjoc.1999.0940

Different types of FC γ -receptors are involved in anti-Lewis Y antibody induced effector functions in vitro

M Dettke 1,2, H Loibner 2
PMCID: PMC2363301  PMID: 10646902

Abstract

Stimulation of monocytes by interaction of monoclonal antibodies (mAbs) with Fc gamma receptors (FcγRs) results in the activation of various monocyte effector functions. In the present investigation we show that the anti-Lewis Y (LeY) anti-tumour mAb ABL 364 and its mouse/human IgG1 chimaera induce both antibody-dependent cellular cytotoxicity (ADCC) and the release of tumour necrosis factor α (TNF-α) during mixed culture of monocytes with LeY+SKBR5 breast cancer cells in vitro. Although anti-LeY mAb-mediated TNF-α release paralleled ADCC activity, cytokine release required a higher concentration of sensitizing mAb than the induction of cytolysis. The determination of the FcγR classes involved in the induction of the distinct effector functions showed that anti-LeY mAb-induced cytolysis was triggered by interaction between anti-LeY mAbs and FcγRI. In contrast, mAb-induced TNF-α release mainly depended on the activation of monocyte FcγRII. Neutralization of TNF-α showed no influence on monocyte ADCC activity towards SKBR5 target cells. Our data indicate an independent regulation of anti-LeY mAb induced effector functions of ADCC and TNF-α release which seemed to be triggered by activation of different types of FcγR. © 2000 Cancer Research Campaign

Keywords: monocytes, anti-LeY antibody, FcγR, ADCC, TNF-α

Full Text

The Full Text of this article is available as a PDF (73.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Blaszczyk-Thurin M., Thurin J., Hindsgaul O., Karlsson K. A., Steplewski Z., Koprowski H. Y and blood group B type 2 glycolipid antigens accumulate in a human gastric carcinoma cell line as detected by monoclonal antibody. Isolation and characterization by mass spectrometry and NMR spectroscopy. J Biol Chem. 1987 Jan 5;262(1):372–379. [PubMed] [Google Scholar]
  2. Bonta I. L., Ben-Efraim S. Involvement of inflammatory mediators in macrophage antitumor activity. J Leukoc Biol. 1993 Dec;54(6):613–626. doi: 10.1002/jlb.54.6.613. [DOI] [PubMed] [Google Scholar]
  3. Boot J. H., Geerts M. E., Aarden L. A. Functional polymorphisms of Fc receptors in human monocyte-mediated cytotoxicity towards erythrocytes induced by murine isotype switch variants. J Immunol. 1989 Feb 15;142(4):1217–1223. [PubMed] [Google Scholar]
  4. Bungard S., Flieger D., Schweitzer S., Sauerbruch T., Spengler U. The combination of interleukin-2 and interferon alpha effectively augments the antibody-dependent cellular cytotoxicity of monoclonal antibodies 17-1A and BR55-2 against the colorectal carcinoma cell line HT29. Cancer Immunol Immunother. 1998 Jun;46(4):213–220. doi: 10.1007/s002620050480. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Calzada-Wack J. C., Frankenberger M., Ziegler-Heitbrock H. W. Interleukin-10 drives human monocytes to CD16 positive macrophages. J Inflamm. 1996;46(2):78–85. [PubMed] [Google Scholar]
  6. Cassel D. L., Keller M. A., Surrey S., Schwartz E., Schreiber A. D., Rappaport E. F., McKenzie S. E. Differential expression of Fc gamma RIIA, Fc gamma RIIB and Fc gamma RIIC in hematopoietic cells: analysis of transcripts. Mol Immunol. 1993 Apr;30(5):451–460. doi: 10.1016/0161-5890(93)90113-p. [DOI] [PubMed] [Google Scholar]
  7. Co M. S., Baker J., Bednarik K., Janzek E., Neruda W., Mayer P., Plot R., Stumper B., Vasquez M., Queen C. Humanized anti-Lewis Y antibodies: in vitro properties and pharmacokinetics in rhesus monkeys. Cancer Res. 1996 Mar 1;56(5):1118–1125. [PubMed] [Google Scholar]
  8. Davenport R. D., Burdick M., Strieter R. M., Kunkel S. L. Monocyte chemoattractant protein production in red cell incompatibility. Transfusion. 1994 Jan;34(1):16–19. doi: 10.1046/j.1537-2995.1994.34194098596.x. [DOI] [PubMed] [Google Scholar]
  9. DeMarco R., Ensor J. E., Hasday J. D. Tumor-stimulated release of tumor necrosis factor-alpha by human monocyte-derived macrophages. Cell Immunol. 1992 Apr;140(2):304–318. doi: 10.1016/0008-8749(92)90198-x. [DOI] [PubMed] [Google Scholar]
  10. Debets J. M., Van de Winkel J. G., Ceuppens J. L., Dieteren I. E., Buurman W. A. Cross-linking of both Fc gamma RI and Fc gamma RII induces secretion of tumor necrosis factor by human monocytes, requiring high affinity Fc-Fc gamma R interactions. Functional activation of Fc gamma RII by treatment with proteases or neuraminidase. J Immunol. 1990 Feb 15;144(4):1304–1310. [PubMed] [Google Scholar]
  11. Deo Y. M., Graziano R. F., Repp R., van de Winkel J. G. Clinical significance of IgG Fc receptors and Fc gamma R-directed immunotherapies. Immunol Today. 1997 Mar;18(3):127–135. doi: 10.1016/s0167-5699(97)01007-4. [DOI] [PubMed] [Google Scholar]
  12. Guyre P. M., Graziano R. F., Vance B. A., Morganelli P. M., Fanger M. W. Monoclonal antibodies that bind to distinct epitopes on Fc gamma RI are able to trigger receptor function. J Immunol. 1989 Sep 1;143(5):1650–1655. [PubMed] [Google Scholar]
  13. Herrmann F., De Vos S., Brach M., Riedel D., Lindemann A., Mertelsmann R. Secretion of granulocyte-macrophage colony-stimulating factor by human blood monocytes is stimulated by engagement of Fc gamma receptors type I by solid-phase immunoglobulins requiring high-affinity Fc-Fc gamma receptor type I interactions. Eur J Immunol. 1992 Jul;22(7):1681–1685. doi: 10.1002/eji.1830220703. [DOI] [PubMed] [Google Scholar]
  14. Jänicke R., Männel D. N. Distinct tumor cell membrane constituents activate human monocytes for tumor necrosis factor synthesis. J Immunol. 1990 Feb 1;144(3):1144–1150. [PubMed] [Google Scholar]
  15. Ling Z. D., Ziltener H. J., Webb B. T., Matheson D. S. Aggregated immunoglobulin and Fc fragment of IgG induce IL-6 release from human monocytes. Cell Immunol. 1990 Aug;129(1):95–103. doi: 10.1016/0008-8749(90)90189-x. [DOI] [PubMed] [Google Scholar]
  16. Lubeck M. D., Steplewski Z., Baglia F., Klein M. H., Dorrington K. J., Koprowski H. The interaction of murine IgG subclass proteins with human monocyte Fc receptors. J Immunol. 1985 Aug;135(2):1299–1304. [PubMed] [Google Scholar]
  17. Marsh C. B., Gadek J. E., Kindt G. C., Moore S. A., Wewers M. D. Monocyte Fc gamma receptor cross-linking induces IL-8 production. J Immunol. 1995 Sep 15;155(6):3161–3167. [PubMed] [Google Scholar]
  18. Munn D. H., McBride M., Cheung N. K. Role of low-affinity Fc receptors in antibody-dependent tumor cell phagocytosis by human monocyte-derived macrophages. Cancer Res. 1991 Feb 15;51(4):1117–1123. [PubMed] [Google Scholar]
  19. Petroni K. C., Shen L., Guyre P. M. Modulation of human polymorphonuclear leukocyte IgG Fc receptors and Fc receptor-mediated functions by IFN-gamma and glucocorticoids. J Immunol. 1988 May 15;140(10):3467–3472. [PubMed] [Google Scholar]
  20. Salmon J. E., Millard S. S., Brogle N. L., Kimberly R. P. Fc gamma receptor IIIb enhances Fc gamma receptor IIa function in an oxidant-dependent and allele-sensitive manner. J Clin Invest. 1995 Jun;95(6):2877–2885. doi: 10.1172/JCI117994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Schlimok G., Pantel K., Loibner H., Fackler-Schwalbe I., Riethmüller G. Reduction of metastatic carcinoma cells in bone marrow by intravenously administered monoclonal antibody: towards a novel surrogate test to monitor adjuvant therapies of solid tumours. Eur J Cancer. 1995 Oct;31A(11):1799–1803. doi: 10.1016/0959-8049(95)00317-c. [DOI] [PubMed] [Google Scholar]
  22. Scholz D., Lubeck M., Loibner H., McDonald-Smith J., Kimoto Y., Koprowski H., Steplewski Z. Biological activity in the human system of isotype variants of oligosaccharide-Y-specific murine monoclonal antibodies. Cancer Immunol Immunother. 1991;33(3):153–157. doi: 10.1007/BF01756135. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Shaw D. R., Khazaeli M. B., LoBuglio A. F. Mouse/human chimeric antibodies to a tumor-associated antigen: biologic activity of the four human IgG subclasses. J Natl Cancer Inst. 1988 Dec 7;80(19):1553–1559. doi: 10.1093/jnci/80.19.1553. [DOI] [PubMed] [Google Scholar]
  24. Steplewski Z., Blaszczyk-Thurin M., Lubeck M., Loibner H., Scholz D., Koprowski H. Oligosaccharide Y specific monoclonal antibody and its isotype switch variants. Hybridoma. 1990 Apr;9(2):201–210. doi: 10.1089/hyb.1990.9.201. [DOI] [PubMed] [Google Scholar]
  25. Tax W. J., Tamboer W. P., Jacobs C. W., Frenken L. A., Koene R. A. Role of polymorphic Fc receptor Fc gammaRIIa in cytokine release and adverse effects of murine IgG1 anti-CD3/T cell receptor antibody (WT31). Transplantation. 1997 Jan 15;63(1):106–112. doi: 10.1097/00007890-199701150-00020. [DOI] [PubMed] [Google Scholar]
  26. Thom D., Powell A. J., Lloyd C. W., Rees D. A. Rapid isolation of plasma membranes in high yield from cultured fibroblasts. Biochem J. 1977 Nov 15;168(2):187–194. doi: 10.1042/bj1680187. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Trevani A. S., Andonegui G. A., Isturiz M. A., Schatner M., Serebrinsky G., Geffner J. R. Effect of proteolytic enzymes on neutrophil Fc gamma RII activity. Immunology. 1994 Aug;82(4):632–637. [PMC free article] [PubMed] [Google Scholar]
  28. Vossebeld P. J., Kessler J., von dem Borne A. E., Roos D., Verhoeven A. J. Heterotypic Fc gamma R clusters evoke a synergistic Ca2+ response in human neutrophils. J Biol Chem. 1995 May 5;270(18):10671–10679. doi: 10.1074/jbc.270.18.10671. [DOI] [PubMed] [Google Scholar]
  29. Wing M. G., Moreau T., Greenwood J., Smith R. M., Hale G., Isaacs J., Waldmann H., Lachmann P. J., Compston A. Mechanism of first-dose cytokine-release syndrome by CAMPATH 1-H: involvement of CD16 (FcgammaRIII) and CD11a/CD18 (LFA-1) on NK cells. J Clin Invest. 1996 Dec 15;98(12):2819–2826. doi: 10.1172/JCI119110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. van de Winkel J. G., Boonen G. J., Janssen P. L., Vlug A., Hogg N., Tax W. J. Activity of two types of Fc receptors, Fc gamma RI and Fc gamma RII, in human monocyte cytotoxicity to sensitized erythrocytes. Scand J Immunol. 1989 Jan;29(1):23–31. doi: 10.1111/j.1365-3083.1989.tb01095.x. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES